Biolocity offers funding opportunities for biomedical technologies through its partnership with Emory University and Georgia Institute of Technology. Eligible technologies must demonstrate a positive impact on human health and compelling evidence of commercial potential. Technologies and therapeutics with preliminary proof of concept data and a clear pathway to private sector translation are highly sought after.

A vital aspect of the Biolocity funding application process is the comprehensive market diligence conducted for each technology. Leveraging industry best practices and venture capital methodologies, the evaluation process assesses the commercial potential of each project and recommends suitable commercialization models. Even if applicants are not selected for final funding, they still benefit from the research conducted and receive a copy of the diligence reports specifically created for their technologies. This valuable market diligence provides insights and guidance for further development and commercialization efforts.

What Does Biolocity Fund?

Biolocity provides a combination of funding, project management, and consulting resources to early-stage technologies that address an unmet clinical need and have compelling commercial potential.  This includes innovations within any clinical discipline with the ability to impact patient health.

Funding For a Broad Range of Technology Types

Annual Program Funds for Distribution

Each funding cycle, over $1.5 million in funding and commercialization support is available for distribution. Technology development support is provided through project management, strategy and business planning, marketing, regulatory, and reimbursement consulting. There is no funding limit per project, however budgets are based on commercialization milestones identified as the most critical next step for development during the application process. 


  • Intellectual property rights must be held (at least in part) by one of our partner institutions:
    • Emory University
    • Georgia Institute of Technology
  • At least one principal investigator must be affiliated with Emory or Georgia Tech
  • Technology must positively impact human health with compelling evidence for commercial potential
  • Two principal investigators preferred – one technical expert and one clinical expert


Funding typically lasts between 6 to 18 months (average project time is 12 months) with grant duration determined by project milestones. No-cost extension requests are reviewed on a case-by-case basis and renewal applications are by invitation only.